Amneal Pharmaceuticals, Inc. financial data

Symbol
AMRX on Nasdaq
Location
Bridgewater, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 156% % 5.6%
Quick Ratio 58% % -2.3%
Return On Equity 369% % 21792%
Return On Assets -5% % -7379%
Operating Margin 12% % 74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 314,362,920 shares 1.5%
Entity Public Float $1,600,000,000 USD 245%
Weighted Average Number of Shares Outstanding, Basic 314,168,000 shares 1.5%
Weighted Average Number of Shares Outstanding, Diluted 324,754,000 shares 4.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,934,959,000 USD 9.5%
Research and Development Expense $205,621,000 USD 13%
Operating Income (Loss) $357,856,000 USD 91%
Nonoperating Income (Expense) $289,201,000 USD 7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $68,655,000 USD -134%
Income Tax Expense (Benefit) $11,037,000 USD -53%
Net Income (Loss) Attributable to Parent $2,369,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $201,249,000 USD 172%
Inventory, Net $614,500,000 USD 3%
Assets, Current $1,838,478,000 USD 21%
Property, Plant and Equipment, Net $434,991,000 USD 0.92%
Operating Lease, Right-of-Use Asset $42,352,000 USD -2.2%
Intangible Assets, Net (Excluding Goodwill) $587,938,000 USD -25%
Goodwill $595,945,000 USD -0.4%
Other Assets, Noncurrent $39,458,000 USD 8.8%
Assets $3,599,874,000 USD 4%
Accounts Payable, Current $266,358,000 USD 13%
Employee-related Liabilities, Current $63,899,000 USD -1.5%
Liabilities, Current $862,106,000 USD -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $105,883,000 USD -44%
Retained Earnings (Accumulated Deficit) $570,081,000 USD 1%
Stockholders' Equity Attributable to Parent $109,458,000 USD -17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $109,955,000 USD -18%
Liabilities and Equity $3,599,874,000 USD 4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,408,000 USD
Net Cash Provided by (Used in) Financing Activities $39,166,000 USD -69%
Net Cash Provided by (Used in) Investing Activities $17,798,000 USD 9.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $50,026,000 USD -5.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $238,407,000 USD 204%
Interest Paid, Excluding Capitalized Interest, Operating Activities $56,323,000 USD -13%
Deferred Tax Assets, Valuation Allowance $590,333,000 USD 4.2%
Deferred Tax Assets, Gross $590,333,000 USD 4.2%
Operating Lease, Liability $47,036,000 USD -3.8%
Payments to Acquire Property, Plant, and Equipment $13,162,000 USD 43%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $26,201,000 USD 90%
Lessee, Operating Lease, Liability, to be Paid $58,754,000 USD -4.2%
Property, Plant and Equipment, Gross $988,428,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $13,496,000 USD -7.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $16,914,000 USD 5.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,718,000 USD -5.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,563,000 USD -1.2%
Deferred Tax Assets, Operating Loss Carryforwards $33,403,000 USD -55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $3,944,000 USD 5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,195,000 USD 5.9%
Additional Paid in Capital $563,363,000 USD 1.8%
Amortization of Intangible Assets $180,900,000 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%